{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:36:55Z","timestamp":1792773415578,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clon.2026.104338","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:40:27Z","timestamp":1788849627000},"page":"104338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Increasing the use of Radical Radiotherapy is Associated with Improved Lung Cancer Specific Survival\u2013A Regional Population-based Patient-level Study"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8908-4581","authenticated-orcid":false,"given":"M.","family":"McMahon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9564-8878","authenticated-orcid":false,"given":"J.","family":"McAleese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0076-7685","authenticated-orcid":false,"given":"D.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0322-1223","authenticated-orcid":false,"given":"F.","family":"Bannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-9732","authenticated-orcid":false,"given":"G.","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-0471","authenticated-orcid":false,"given":"A.","family":"Bedair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2053-7078","authenticated-orcid":false,"given":"D.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2026.104338_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2026.104338_bib3","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2026.104338_bib4","series-title":"National lung cancer audit","year":"2024"},{"issue":"6","key":"10.1016\/j.clon.2026.104338_bib5","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/j.clon.2024.03.014","article-title":"Service Improvements and Workload Increases: Royal College of Radiologists (RCR) Re-Audit of Curative Intent Radiotherapy for Non-Small Cell Lung Cancer (NSCLC)","volume":"36","author":"McAleese","year":"2024","journal-title":"Clin Oncol"},{"issue":"10","key":"10.1016\/j.clon.2026.104338_bib6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.clon.2019.07.020","article-title":"Stage III Non-small Cell Lung Cancer Management in England","volume":"31","author":"Adizie","year":"2019","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2026.104338_bib7","first-page":"12","article-title":"A systematic review of the impact of stigma and nihilism on lung cancer outcomes","volume":"20","author":"Chambers","year":"2012","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.clon.2026.104338_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9687","key":"10.1016\/j.clon.2026.104338_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial","volume":"374","author":"Albain","year":"2009","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.clon.2026.104338_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/djk093","article-title":"Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer","volume":"99","author":"van Meerbeeck","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.clon.2026.104338_bib11","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104338_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2015.08.011","article-title":"Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial","volume":"117","author":"Louie","year":"2015","journal-title":"Radiother Oncol"},{"issue":"1104","key":"10.1016\/j.clon.2026.104338_bib13","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190524","article-title":"The evolving role of radiotherapy in non-small cell lung cancer","volume":"92","author":"Brown","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2026.104338_bib14","article-title":"Multimodality curative-intent treatment in NSCLC: an unprecedented era of change 2017\u20132025","author":"Evison","year":"2025","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.clon.2026.104338_bib15","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S1470-2045(23)00511-9","article-title":"The future of cancer care in the UK\u2014time for a radical and sustainable National Cancer Plan","volume":"25","author":"Aggarwal","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2026.104338_bib16","series-title":"Radiotherapy: accessibility - UK Parliamentary Debate","year":"2023"},{"issue":"6","key":"10.1016\/j.clon.2026.104338_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1470-2045(23)00182-1","article-title":"Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments","volume":"24","author":"McIntosh","year":"2023","journal-title":"Lancet Oncol"},{"issue":"7624","key":"10.1016\/j.clon.2026.104338_bib19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.clon.2026.104338_bib20","series-title":"Cancer incidence, survival and prevalence statistics- Methodology report","year":"2024"},{"issue":"9","key":"10.1016\/j.clon.2026.104338_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.clon.2015.05.010","article-title":"The Impact of Colleague Peer Review on the Radiotherapy Treatment Planning Process in the Radical Treatment of Lung Cancer","volume":"27","author":"Rooney","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2026.104338_bib22","series-title":"International classification of diseases for oncology","first-page":"242","author":"Fritz","year":"2014"},{"issue":"1","key":"10.1016\/j.clon.2026.104338_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jtcvs.2017.08.138","article-title":"The eighth edition TNM stage classification for lung cancer: What does it mean on main street?","volume":"155","author":"Detterbeck","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"40","key":"10.1016\/j.clon.2026.104338_bib24","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.18158","article-title":"Evaluation of the 7th and 8th editions of the AJCC\/UICC TNM staging systems for lung cancer in a large North American cohort","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.clon.2026.104338_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0197-2456(03)00072-2","article-title":"On the use and utility of the Weibull model in the analysis of survival data","volume":"24","author":"Carroll","year":"2003","journal-title":"Control Clin Trial"},{"issue":"6","key":"10.1016\/j.clon.2026.104338_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.clon.2026.104338_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jpainsymman.2014.06.006","article-title":"Comparison of ECOG\/WHO performance status and ASA score as a measure of functional status","volume":"49","author":"Young","year":"2015","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.clon.2026.104338_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejca.2011.07.012","article-title":"Variation in surgical resection for lung cancer in relation to survival: Population-based study in England 2004-2006","volume":"48","author":"Riaz","year":"2012","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.clon.2026.104338_bib29","article-title":"Optimal resection rate for lung cancer in the UK: How high should we go?","volume":"8","author":"Belcher","year":"2021","journal-title":"BMJ Open Respir Res"},{"issue":"10","key":"10.1016\/j.clon.2026.104338_bib30","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/annonc\/mds081","article-title":"Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands","volume":"23","author":"Haasbeek","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2026.104338_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110153","article-title":"The management of stage I Non-Small cell lung cancer (NSCLC) in Ontario: A Population-Based study of patterns of care and Stereotactic Ablative Body radiotherapy (SABR) utilization from 2010 to 2019","volume":"194","author":"Ashworth","year":"2024","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.clon.2026.104338_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.clon.2019.07.013","article-title":"Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer","volume":"31","author":"Phillips","year":"2019","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2026.104338_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.radonc.2018.10.015","article-title":"Improving outcomes in non-small cell lung cancer; population analysis of radical radiotherapy","volume":"132","author":"Brada","year":"2019","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.clon.2026.104338_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/thoraxjnl-2017-210710","article-title":"Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients","volume":"73","author":"M\u00f8ller","year":"2018","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.clon.2026.104338_bib35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10198-023-01623-5","article-title":"Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis","volume":"25","author":"Wills","year":"2024","journal-title":"Eur J Health Econ"},{"issue":"3","key":"10.1016\/j.clon.2026.104338_bib36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.radonc.2018.04.013","article-title":"Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer","volume":"128","author":"Paix","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104338_bib37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijrobp.2010.06.025","article-title":"Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: A dose-escalation planning study","volume":"80","author":"Lievens","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2026.104338_bib38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.21037\/jtd-22-925","article-title":"Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer","volume":"15","author":"Gouran-Savadkoohi","year":"2023","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.clon.2026.104338_bib39","series-title":"National lung cancer audit","year":"2023"},{"issue":"1","key":"10.1016\/j.clon.2026.104338_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clon.2021.10.009","article-title":"Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK","volume":"34","author":"Banfill","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526003092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526003092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:06:23Z","timestamp":1792767983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526003092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S0936655526003092"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104338","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing the use of Radical Radiotherapy is Associated with Improved Lung Cancer Specific Survival\u2013A Regional Population-based Patient-level Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"104338"}}